Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
30.00
+0.21 (0.70%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.
| Country | Costa Rica |
| Founded | 2004 |
| IPO Date | Jul 19, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,018 |
| CEO | Filippo Caldini |
Contact Details
Address: Building B23 and B25, Coyol Free Zone Alajuela Costa Rica | |
| Phone | 506 2434 2400 |
| Website | establishmentlabs.com |
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| Employer ID | 98-1436377 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Filippo Caldini | Interim Chief Executive Officer |
| Juan Jose Chacon Quiros | Founder and Executive Director |
| Rajbir Singh Denhoy | Chief Financial Officer |
| S. Ross Mansbach | General Counsel, Chief Compliance Officer and Chief Human Resources Officer |
| Roberto de Mezerville | Chief Technology Officer |
| Salvador Santos Dada | Head of Special Projects |
| Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical and US Regulatory Affairs |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Jeff Ehrhardt | Senior Vice President and GM of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2025 | ARS | Filing |
| Apr 10, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 10, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 10, 2025 | SCHEDULE 13G | Filing |
| Apr 10, 2025 | 8-K | Current Report |
| Feb 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |